Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPOWER: Prehospital Whole Blood for Hemorrhagic Shock
NCT03477006Phase 3Terminated
- Start
- Nov 2018
- Primary completion
- Oct 2020
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
A Phase 3 trial of low-titer group O whole blood in hemorrhagic shock. Started Nov 2018; status: terminated.
02
Drugs
low-titer group O whole blood
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on NCT03477006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03477006.